Cognitive Impairment in HIV-Positive Individuals in Botswana
Author Information
Author(s): Kathy Lawler, Jeremiah Kealeboga, Mosepele Mosepele, Sarah J. Ratcliffe, Catherine Cherry, Seloilwe Esther, Andew P. Steenhoff
Primary Institution: Center for the Study of HIV and AIDS, University of Botswana
Hypothesis
What is the prevalence and features of HIV-associated neurocognitive disorders in Botswana?
Conclusion
Neurocognitive impairment is common among HIV-positive individuals in Botswana, highlighting the need for effective treatments.
Supporting Evidence
- 37% of HIV-positive patients met criteria for cognitive impairment.
- HIV-positive subjects were impaired in all cognitive-motor ability areas compared to controls.
- Older age and fewer years of education were associated with cognitive impairment in HIV-positive individuals.
- All HIV-positive subjects were receiving highly active antiretroviral therapy (HAART).
- Neurocognitive impairment is likely to be an important feature of HIV infection in resource-limited countries.
Takeaway
This study found that many people with HIV in Botswana have trouble thinking and remembering, which is important to know so they can get the help they need.
Methodology
A cross-sectional study of 60 HIV-positive individuals and 80 matched HIV-negative controls using neuropsychological tests and structured interviews.
Potential Biases
Potential cultural bias in the assessment tools used.
Limitations
The study had a small sample size and used a symptom scale for neuropathy instead of a medical assessment.
Participant Demographics
Participants included 60 HIV-positive individuals aged 21-50 and 80 matched HIV-negative controls.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website